Los Angeles Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Amgen, Merck Expand Cancer Research

Amgen Inc. will expand its collaboration with Merck on research seeking a cure for a special type of head and neck cancer, the company announced Friday.

Friday Rundown: Puma Report On Tap, LAX Traffic Takeoff Continues, Zipcar and Metro Team Up

Puma to Unpack Drug Study Puma Biotechnology Inc. on Monday morning will reveal additional details from a pivotal study of its breast cancer drug at the American Society of Clinical Oncology’s annual meeting in Chicago.

Suicide Concerns Dissolve Amgen Partnership

Amgen Inc. will end a partnership to develop a drug for psoriasis because it could face restrictive labeling due to concerns from regulatory agencies that it might lead to suicidal thoughts.

E.U. Panel Backs Amgen Cholesterol Drug

Amgen Inc. announced Friday that a European Union committee has recommended approval of its drug Repatha to treat high cholesterol.

DaVita Consolidates in Large El Segundo Lease Deal

DaVita HealthCare Partners Inc. wanted to “DaVita-ize” its California presence.

Molina Continues Expansion with Michigan Buy

Long Beach’s fast-growing managed care provider Molina Healthcare Inc. plans to add to its Medicaid contract holdings, announcing plans Friday to acquire the Medicaid contract businesses of HealthPlus of Michigan Inc. and its subsidiary, HealthPlus Partners Inc. through Molina’s Michigan subsidiary.

Puma Shares Fall on Study Results

Puma Biotechnology Inc. shares took a nosedive on Thursday in the wake of newly released data from a clinical trial for its breast cancer drug neratinib.

Health Net Shifts 2,000 Employees to Contractor

More than 2,000 employees are being laid off Health Net Inc. but will be offered jobs with information technology contractor Cognizant Technology Solutions Corp. as part of a multi-year agreement, the health insurer said Wednesday.

Soon-Shiong’s NantWorks Unit Gets $100 Million Infusion

A subsidiary of billionaire Patrick Soon-Shiong’s NantWorks health care technology company has secured $100 million in equity funding, according to regulatory filings.

Amgen Granted Novartis Injunction

An appeals court has blocked sales of Zarxio, a copycat version of Amgen Inc.’s blockbuster drug Neupogen.

Briefs: Tutor Perini Wins New York Contract, Molina Tops Estimates

Tutor Perini Corp. Gets $56.3 Million Contract Tutor Perini Corp. has won a $56.3 million contract from Amtrak for the Hudson Yards project in New York City.

Big Gift for Research Institute

The Los Angeles Biomedical Research Institute announced Wednesday it had received its biggest ever donation: a $3 million contribution to help build a new research facility.

Hawthorne Woman Sentenced in Medicare Scam

A Hawthorne woman has been sentenced for submitting more than $7 million through her company in fraudulent claims to Medicare primarily for power wheelchair that patients did not need.

City Charges a Hawaiian Gardens Hospital With Patient Dumping

City Attorney Mike Feuer has filed a lawsuit against Gardens Regional Hospital and Medical Center Inc. for alleged patient dumping on Skid Row.

Kythera Drug Gets FDA Approval

A fat-dissolving drug from Kythera Biopharmaceuticals Inc. that reduces double chins was approved by the Food and Drug Administration Wednesday.